Continuous cardiac monitoring in a patient with terminal pulmonary hypertension and eventual bilateral lung transplantation

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Continuous cardiac monitoring in a patient with terminal pulmonary hypertension and eventual bilateral lung transplantation. / Andersen, Mads Ørbæk; Diederichsen, Soeren; Svendsend, Jesper Hastrup; Carlsen, Jørn.

I: BMJ Case Reports, Bind 15, Nr. 6, e248304, 2022.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Andersen, MØ, Diederichsen, S, Svendsend, JH & Carlsen, J 2022, 'Continuous cardiac monitoring in a patient with terminal pulmonary hypertension and eventual bilateral lung transplantation', BMJ Case Reports, bind 15, nr. 6, e248304. https://doi.org/10.1136/bcr-2021-248304

APA

Andersen, M. Ø., Diederichsen, S., Svendsend, J. H., & Carlsen, J. (2022). Continuous cardiac monitoring in a patient with terminal pulmonary hypertension and eventual bilateral lung transplantation. BMJ Case Reports, 15(6), [e248304]. https://doi.org/10.1136/bcr-2021-248304

Vancouver

Andersen MØ, Diederichsen S, Svendsend JH, Carlsen J. Continuous cardiac monitoring in a patient with terminal pulmonary hypertension and eventual bilateral lung transplantation. BMJ Case Reports. 2022;15(6). e248304. https://doi.org/10.1136/bcr-2021-248304

Author

Andersen, Mads Ørbæk ; Diederichsen, Soeren ; Svendsend, Jesper Hastrup ; Carlsen, Jørn. / Continuous cardiac monitoring in a patient with terminal pulmonary hypertension and eventual bilateral lung transplantation. I: BMJ Case Reports. 2022 ; Bind 15, Nr. 6.

Bibtex

@article{fff59b433b704a83a79562aca23417b7,
title = "Continuous cardiac monitoring in a patient with terminal pulmonary hypertension and eventual bilateral lung transplantation",
abstract = "As pulmonary arterial hypertension (PAH) progress, arrhythmias are becoming an increasingly prominent phenomenon. Supraventricular tachycardias have been shown to have an incidence of up to 35% in pulmonary hypertension. Continuous cardiac monitoring was deployed in a patient with severe PAH 100 days before bilateral lung transplantation (BLTX). Despite being graded as WHO functional class IV, no arrhythmias were observed before BLTX. Furthermore, the case describes clinical improvement, along with a significant increase in heart rate variability (HRV) and decrease in night-time heart rate in the post-transplantation period. No arrhythmias were observed preoperatively during continuous monitoring in a 100-day period despite the patient's intrinsically high risk for arrhythmias. Increasing HRV and lower resting heart rate were observed after BLTX. Since these parameters correlate with the clinical condition, they might be valuable in risk assessment in patients with pulmonary hypertension.",
keywords = "Arrhythmias, Pulmonary hypertension",
author = "Andersen, {Mads {\O}rb{\ae}k} and Soeren Diederichsen and Svendsend, {Jesper Hastrup} and J{\o}rn Carlsen",
note = "Publisher Copyright: {\textcopyright} BMJ Publishing Group Limited 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.",
year = "2022",
doi = "10.1136/bcr-2021-248304",
language = "English",
volume = "15",
journal = "BMJ Case Reports",
issn = "1757-790X",
publisher = "BMJ Publishing Group",
number = "6",

}

RIS

TY - JOUR

T1 - Continuous cardiac monitoring in a patient with terminal pulmonary hypertension and eventual bilateral lung transplantation

AU - Andersen, Mads Ørbæk

AU - Diederichsen, Soeren

AU - Svendsend, Jesper Hastrup

AU - Carlsen, Jørn

N1 - Publisher Copyright: © BMJ Publishing Group Limited 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

PY - 2022

Y1 - 2022

N2 - As pulmonary arterial hypertension (PAH) progress, arrhythmias are becoming an increasingly prominent phenomenon. Supraventricular tachycardias have been shown to have an incidence of up to 35% in pulmonary hypertension. Continuous cardiac monitoring was deployed in a patient with severe PAH 100 days before bilateral lung transplantation (BLTX). Despite being graded as WHO functional class IV, no arrhythmias were observed before BLTX. Furthermore, the case describes clinical improvement, along with a significant increase in heart rate variability (HRV) and decrease in night-time heart rate in the post-transplantation period. No arrhythmias were observed preoperatively during continuous monitoring in a 100-day period despite the patient's intrinsically high risk for arrhythmias. Increasing HRV and lower resting heart rate were observed after BLTX. Since these parameters correlate with the clinical condition, they might be valuable in risk assessment in patients with pulmonary hypertension.

AB - As pulmonary arterial hypertension (PAH) progress, arrhythmias are becoming an increasingly prominent phenomenon. Supraventricular tachycardias have been shown to have an incidence of up to 35% in pulmonary hypertension. Continuous cardiac monitoring was deployed in a patient with severe PAH 100 days before bilateral lung transplantation (BLTX). Despite being graded as WHO functional class IV, no arrhythmias were observed before BLTX. Furthermore, the case describes clinical improvement, along with a significant increase in heart rate variability (HRV) and decrease in night-time heart rate in the post-transplantation period. No arrhythmias were observed preoperatively during continuous monitoring in a 100-day period despite the patient's intrinsically high risk for arrhythmias. Increasing HRV and lower resting heart rate were observed after BLTX. Since these parameters correlate with the clinical condition, they might be valuable in risk assessment in patients with pulmonary hypertension.

KW - Arrhythmias

KW - Pulmonary hypertension

U2 - 10.1136/bcr-2021-248304

DO - 10.1136/bcr-2021-248304

M3 - Journal article

C2 - 35667702

AN - SCOPUS:85131344844

VL - 15

JO - BMJ Case Reports

JF - BMJ Case Reports

SN - 1757-790X

IS - 6

M1 - e248304

ER -

ID: 323983544